Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France

Meffre C, Le Strat Y, Delarocque-Astagneau E, Antona D, Desenclos JC. Prévalence des hépatites B et C en France en 2004; 2006. http://www.invs.sante.fr/publications/2006/prevalence_b_c/index.htm.

WHO. Hepatitis B: World Health Organization Fact Sheet 204; 2008. http://www.who.int/mediacentre/factsheets/fs204/en/.

Marcellin, 2008, Mortality related to chronic hepatitis B and chronic hepatitis C in France. Evidence for the role of HIV coinfection and alcohol consumption, J Hepatol, 48, 200, 10.1016/j.jhep.2007.09.010

Weinbaum, 2008, Recommendations for identification and public health management of persons with chronic hepatitis B virus infection, MMWR Recomm Rep, 57, 1

DGS. Plan national de lutte contre les hépatites B et C (2009-2012). 2009. http://www.sante-sports.gouv.fr/IMG/pdf/Plan_hepatites_2009_2012.pdf.

Villeneuve, 2003, Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient, J Hepatol, 39, 1085, 10.1016/j.jhep.2003.09.022

Pepe, 2003

Morrison, 1992

WHO. Hepatitis B surface antigen assays: operational characteristics (phase I). Blood safety and clinical technology. WHO: Geneva, Switzerland; 2001. www.who.int/diagnostics_laboratory/evaluations/en/hep_B_rep1.pdf.

Lin, 2008, Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity, J Clin Microbiol, 46, 3319, 10.1128/JCM.00498-08

Randrianirina, 2008, Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar, J Virol Methods, 151, 294, 10.1016/j.jviromet.2008.03.019

Geretti, 2010, Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana, J Clin Microbiol, 48, 3223, 10.1128/JCM.02231-09

Pawlotsky, 2009, EASL clinical practice guidelines, J Hepatol, 50, 243, 10.1016/j.jhep.2008.11.012

Maimone, 2009, An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers, J Viral Hepat, 16, 769, 10.1111/j.1365-2893.2009.01120.x

Brunetto, 2010, Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers, Gastroenterology, 139, 483, 10.1053/j.gastro.2010.04.052

Chen, 2010, Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death, Gastroenterology, 138, 1747, 10.1053/j.gastro.2010.01.042

Lada, 2006, Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of “a” determinant variants, J Virol, 80, 2968, 10.1128/JVI.80.6.2968-2975.2006

Carman, 1990, Vaccine-induced escape mutant of hepatitis B virus, Lancet, 336, 325, 10.1016/0140-6736(90)91874-A

Tian, 2007, The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen, J Clin Microbiol, 45, 2971, 10.1128/JCM.00508-07

Weber, 2006, Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene, J Med Virol, 78, S59, 10.1002/jmv.20610

Hutchinson, 2006, A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status, AIDS, 20, 1597, 10.1097/01.aids.0000238405.93249.16

Thornton, 2012, HIV testing in community settings in resource-rich countries: a systematic review of the evidence, HIV Med, 10.1111/j.1468-1293.2012.00992.x